Maryam AlSaeed

Ms. Maryam AlSaeed

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 August 2024 in Clinical and Translational Science
Verified
Journal Article
Open access
LCLarisa H. Cavallari
Larisa H. Cavallari
CLCraig R. Lee
Craig R. Lee
FFFrancesco Franchi
Francesco Franchi
EKEllen C. Keeley
Ellen C. Keeley
JRJoseph S. Rossi
Joseph S. Rossi
Dominick Joseph AngiolilloDominick Joseph Angiolillo
Dominick Joseph Angiolillo
Dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 receptor inhibitor (clopidogrel, prasugrel, or ticagrelor) is indicated after percutaneous coronary intervention (PCI) to reduce the risk of atherothrombotic events. Approximately 30% of the US population has a CYP2C19 no‐function allele that reduces the effectiveness of clopidogrel, but not prasugrel or ticagrelor, after PCI. We have shown improved outcomes with the integration of CYP2C19 genotyping into clinical care to guide the selection of prasugrel or ticagrelor in CYP2C19 no‐function allele carriers. However, the influence of patient‐specific demographic, clinical, and other genetic factors on outcomes with genotype‐guided DAPT has not been defined. In addition, the impact of genotype‐guided de‐escalation from prasugrel or ticagrelor to clopidogrel in patients without a CYP2C19 no‐function allele has not been investigated in a diverse, real‐world clinical setting. The Precision Antiplatelet Therapy after Percutaneous Coronary Intervention (Precision PCI) Registry is a multicenter US registry of patients who underwent PCI and clinical CYP2C19 testing. The registry is enrolling a diverse population, assessing atherothrombotic and bleeding events over 12 months, collecting DNA samples, and conducting platelet function testing in a subset of patients. The registry aims to define the influence of African ancestry and other patient‐specific factors on clinical outcomes with CYP2C19‐guided DAPT, evaluate the safety and effectiveness of CYP2C19‐guided DAPT de‐escalation following PCI in a real‐world setting, and identify additional genetic influences of clopidogrel response after PCI, with the ultimate goal of establishing optimal strategies for individualized antiplatelet therapy that improves outcomes in a diverse, real‐world population.

19 July 2024 in Clinical Pharmacology & Therapeutics
Verified
Journal Article
Closed access
MAMaryam AlSaeed
Maryam AlSaeed
CTCameron D. Thomas
Cameron D. Thomas
FFFrancesco Franchi
Francesco Franchi
EKEllen C. Keeley
Ellen C. Keeley
JDJulio D. Duarte
Julio D. Duarte
LCLarisa H. Cavallari
Larisa H. Cavallari

MAMaryam AlSaeed
Maryam AlSaeed
Dalia Ahmed ElmaghrabyDalia Ahmed Elmaghraby
Dalia Ahmed Elmaghraby
Background: Pain is a common compensation mechanism in pregnant women that they may face during gestation due to physiological changes. Paracetamol and non-steroidal anti-inflammatory drugs are the most administered analgesic drugs worldwide. Therefore, safety and efficacy are important measures for the use of analgesics during pregnancy. Objective: Assess the knowledge of analgesic drug utilization among Saudi pregnant women. Method: We conducted a self-administered survey with an electronic questionnaire via Google Drive among a sample of 406 Saudi women. Results: About half of the respondents took analgesics during the first trimester, and 52.5% of women have used analgesics at least once without any medical advice during their gestation. Most participants agreed that paracetamol is the safest and effective analgesic drug during pregnancy, yet 61.8% of women are not aware that analgesics could be detrimental to the fetus if inappropriately administered in the third trimester. Conclusion: Participants have a good perception of the safest and most effective analgesic drug during pregnancy, but they have poor knowledge about analgesics’ side effects.

18 June 2024 in Clinical Pharmacology & Therapeutics
Verified
Journal Article
Closed access
MAMaryam AlSaeed
Maryam AlSaeed
PRPeter Ramdhan
Peter Ramdhan
JMJean Gabriel Malave
Jean Gabriel Malave
IEIslam Eljilany
Islam Eljilany
TLTaimour Langaee
Taimour Langaee
LCLarisa H. Cavallari
Larisa H. Cavallari